학술논문
The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p734-734, 1p
Subject
Language
ISSN
0732183X